G. Scalise

发表

In-vitro activity of five antifungal agents against uncommon clinical isolates of Candida spp.

M. Cogliati, A. Tortorano, F. Barchiesi, 1999, The Journal of antimicrobial chemotherapy.

Comparison of the Fungicidal Activities of Caspofungin and Amphotericin B against Candida glabrata

F. Barchiesi, G. Scalise, E. Spreghini, 2005, Antimicrobial Agents and Chemotherapy.

Caspofungin in Combination with Amphotericin B against Candida glabrata

M. Rinaldi, A. Fothergill, F. Barchiesi, 2005, Antimicrobial Agents and Chemotherapy.

Evaluation of the Disk Diffusion Method Compared to the Microdilution Method in Susceptibility Testing of Anidulafungin against Filamentous Fungi

L. Trovato, S. Oliveri, F. Barchiesi, 2008, Journal of Clinical Microbiology.

Posaconazole Activity against Candida glabrata after Exposure to Caspofungin or Amphotericin B

F. Barchiesi, G. Scalise, E. Spreghini, 2007, Antimicrobial Agents and Chemotherapy.

Comparison between Disk Diffusion and Microdilution Methods for Determining Susceptibility of Clinical Fungal Isolates to Caspofungin

S. Oliveri, F. Barchiesi, G. Scalise, 2007, Journal of Clinical Microbiology.

Antimicrobial activity of polycationic peptides

F. Barchiesi, G. Scalise, A. Giacometti, 1999, Peptides.

In Vitro Activities of Membrane-Active Peptides Alone and in Combination with Clinically Used Antimicrobial Agents against Stenotrophomonas maltophilia

F. Barchiesi, G. Scalise, A. Giacometti, 2000, Antimicrobial Agents and Chemotherapy.

In Vitro Susceptibility Tests for Cationic Peptides: Comparison of Broth Microdilution Methods for Bacteria That Grow Aerobically

F. Barchiesi, G. Scalise, A. Giacometti, 2000, Antimicrobial Agents and Chemotherapy.

Short-Term Exposure to Membrane-Active Antibiotics Inhibits Cryptosporidium parvum Infection in Cell Culture

F. Barchiesi, G. Scalise, A. Giacometti, 2000, Antimicrobial Agents and Chemotherapy.

Comparative activities of polycationic peptides and clinically used antimicrobial agents against multidrug-resistant nosocomial isolates of Acinetobacter baumannii.

F. Barchiesi, G. Scalise, A. Giacometti, 2000, The Journal of antimicrobial chemotherapy.

Combination studies between polycationic peptides and clinically used antibiotics against Gram-positive and Gram-negative bacteria

M. D'Errico, G. Scalise, A. Giacometti, 2000, Peptides.

Polycationic Peptides as Prophylactic Agents against Methicillin-Susceptible or Methicillin-Resistant Staphylococcus epidermidis Vascular Graft Infection

L. Goffi, V. Saba, R. Ghiselli, 2000, Antimicrobial Agents and Chemotherapy.

Activity of buforin II alone and in combination with azithromycin and minocycline against Cryptosporidium parvum in cell culture.

F. Barchiesi, G. Scalise, A. Giacometti, 2001, The Journal of antimicrobial chemotherapy.

Cationic peptides combined with betalactams reduce mortality from peritonitis in experimental rat model.

V. Saba, R. Ghiselli, G. Scalise, 2002, The Journal of surgical research.

Potential Therapeutic Role of Cationic Peptides in Three Experimental Models of Septic Shock

W. Kamysz, V. Saba, R. Ghiselli, 2002, Antimicrobial Agents and Chemotherapy.

Antiendotoxin Activity of Antimicrobial Peptides and Glycopeptides

V. Saba, R. Ghiselli, G. Scalise, 2003, Journal of chemotherapy.

Interaction of Antimicrobial Peptide Temporin L with Lipopolysaccharide In Vitro and in Experimental Rat Models of Septic Shock Caused by Gram-Negative Bacteria

D. Barra, A. Rinaldi, M. Mangoni, 2006, Antimicrobial Agents and Chemotherapy.

Efficacy of the Combination of Tachyplesin III and Clarithromycin in Rat Models of Escherichia coli Sepsis

M. Rocchi, W. Kamysz, V. Saba, 2008, Antimicrobial Agents and Chemotherapy.

In vitro susceptibility of dermatophytes to conventional and alternative antifungal agents.

W. Kamysz, A. Offidani, G. Ganzetti, 2009, Medical mycology.

Quantitative molecular monitoring of human immunodeficiency virus type 1 activity during therapy with specific antiretroviral compounds

M. Clementi, A. Manzin, S. Paolucci, 1995, Journal of clinical microbiology.

In Vitro Activities of Voriconazole in Combination with Three Other Antifungal Agents against Candida glabrata

M. Rinaldi, A. Fothergill, F. Barchiesi, 2004, Antimicrobial Agents and Chemotherapy.

Epidemiology and Microbiology of Surgical Wound Infections

M. D'Errico, M. Prete, F. Barchiesi, 2000, Journal of Clinical Microbiology.

Activity of the new antifungal triazole, posaconazole, against Cryptococcus neoformans.

F. Barchiesi, L. Di Francesco, G. Scalise, 2001, The Journal of antimicrobial chemotherapy.

Inhibition of growth of Pneumocystis carinii by lactoferrins alone and in combination with pyrimethamine, clarithromycin and minocycline.

F. Barchiesi, G. Scalise, A. Giacometti, 2000, The Journal of antimicrobial chemotherapy.

In-vitro activity of lytic peptides, inhibitors of ion transport systems and ionophorous antibiotics against Pneumocystis carinii.

F. Barchiesi, G. Scalise, A. Giacometti, 1998, The Journal of antimicrobial chemotherapy.

Comparative activities of cecropin A, melittin, and cecropin A–melittin peptide CA(1–7)M(2–9)NH2 against multidrug-resistant nosocomial isolates of Acinetobacter baumannii

J. Łukasiak, W. Kamysz, G. Scalise, 2003, Peptides.

Prophylactic Efficacy of Topical Temporin A and RNAIII-Inhibiting Peptide in a Subcutaneous Rat Pouch Model of Graft Infection Attributable to Staphylococci With Intermediate Resistance to Glycopeptides

J. Łukasiak, W. Kamysz, V. Saba, 2003, Circulation.

Candida guilliermondii Fungemia in Patients with Hematologic Malignancies

F. Barchiesi, G. Scalise, C. Girmenia, 2006, Journal of Clinical Microbiology.

Posaconazole and Amphotericin B Combination Therapy against Cryptococcus neoformans Infection

F. Barchiesi, G. Scalise, E. Spreghini, 2004, Antimicrobial Agents and Chemotherapy.

Non-Hodgkin’s Lymphomas in Patients with AIDS

F. Lombardi, P. Cazzaniga, S. Pileri, 1990 .

The antimicrobial peptide Tachyplesin III coated alone and in combination with intraperitoneal piperacillin-tazobactam prevents ureteral stent Pseudomonas infection in a rat subcutaneous pouch model

W. Kamysz, V. Saba, R. Ghiselli, 2007, Peptides.

Anidulafungin in Combination with Amphotericin B against Aspergillus fumigatus

C. Loretelli, A. Santinelli, F. Barchiesi, 2009, Antimicrobial Agents and Chemotherapy.

Imipenem and meropenem induced resistance to beta-lactam antibiotics inPseudomonas aeruginosa

G. Scalise, A. Giacometti, O. Cirioni, 1994, European Journal of Clinical Microbiology and Infectious Diseases.

Electrophoretic karyotype and in vitro antifungal susceptibility of Cryptococcus neoformans isolates from AIDS patients.

M. Pfaller, S. Messer, M. Rinaldi, 1995, Diagnostic microbiology and infectious disease.

Comparative efficacy of topical versus systemic teicoplanin in experimental model of wound infections.

V. Saba, A. Offidani, R. Ghiselli, 2008, The Journal of surgical research.

EFFICACY OF LL-37 AND GRANULOCYTE COLONY-STIMULATING FACTOR IN A NEUTROPENIC MURINE SEPSIS DUE TO PSEUDOMONAS AERUGINOSA

M. Rocchi, V. Saba, R. Ghiselli, 2008, Shock.

Cecropin B Enhances Betalactams Activities in Experimental Rat Models of Gram-Negative Septic Shock

V. Saba, R. Ghiselli, G. Scalise, 2004, Annals of surgery.

Antimicrobial susceptibility studies In vitro activity and killing effect of the synthetic hybrid cecropin A-melittin peptide CA(1-7)M(2-9)NH 2 on methicillin-resistant nosocomial isolates of Staphylococcus aureusand interactions with clinically used antibiotics

W. Kamysz, G. Scalise, A. Giacometti, 2004 .

In vitro activity and killing effect of the synthetic hybrid cecropin A-melittin peptide CA(1-7)M(2-9)NH(2) on methicillin-resistant nosocomial isolates of Staphylococcus aureus and interactions with clinically used antibiotics.

W. Kamysz, G. Scalise, A. Giacometti, 2004, Diagnostic microbiology and infectious disease.

Temporin A as a prophylactic agent against methicillin sodium-susceptible and methicillin sodium-resistant Staphylococcus epidermidis vascular graft infection.

W. Kamysz, V. Saba, R. Ghiselli, 2002, Journal of vascular surgery.

Effect of mono-dose intraperitoneal cecropins in experimental septic shock

V. Saba, R. Ghiselli, G. Scalise, 2001, Critical care medicine.

In-vitro activity and killing effect of polycationic peptides on methicillin-resistant Staphylococcus aureus and interactions with clinically used antibiotics.

F. Barchiesi, G. Scalise, A. Giacometti, 2000, Diagnostic microbiology and infectious disease.

In Vitro Activities of Polycationic Peptides Alone and in Combination with Clinically Used Antimicrobial Agents againstRhodococcus equi

G. Scalise, A. Giacometti, O. Cirioni, 1999, Antimicrobial Agents and Chemotherapy.

In-vitro activity of cationic peptides alone and in combination with clinically used antimicrobial agents against Pseudomonas aeruginosa.

F. Barchiesi, G. Scalise, A. Giacometti, 1999, The Journal of antimicrobial chemotherapy.

In Vitro Activities of Membrane-Active Peptides against Gram-Positive and Gram-Negative Aerobic Bacteria

G. Scalise, G. Greganti, A. Giacometti, 1998, Antimicrobial Agents and Chemotherapy.

Protective effects of the combination of alpha-helical antimicrobial peptides and rifampicin in three rat models of Pseudomonas aeruginosa infection.

V. Saba, R. Ghiselli, G. Scalise, 2008, The Journal of antimicrobial chemotherapy.

Efficacy of Tachyplesin III, Colistin, and Imipenem against a Multiresistant Pseudomonas aeruginosa Strain

J. Łukasiak, W. Kamysz, V. Saba, 2007, Antimicrobial Agents and Chemotherapy.

In vitro activities of tachyplesin III against Pseudomonas aeruginosa

J. Łukasiak, W. Kamysz, G. Scalise, 2007, Peptides.

In Vitro Activities of Tritrpticin Alone and in Combination with Other Antimicrobial Agents against Pseudomonas aeruginosa

G. Scalise, A. Giacometti, O. Cirioni, 2006, Antimicrobial Agents and Chemotherapy.

In vitro activity of amphibian peptides alone and in combination with antimicrobial agents against multidrug-resistant pathogens isolated from surgical wound infection

J. Łukasiak, W. Kamysz, G. Scalise, 2005, Peptides.

In Vitro Activity of the Histatin Derivative P-113 against Multidrug-Resistant Pathogens Responsible for Pneumonia in Immunocompromised Patients

J. Łukasiak, W. Kamysz, G. Scalise, 2005, Antimicrobial Agents and Chemotherapy.

In-vitro activity of polycationic peptides against Cryptosporidium parvum, Pneumocystis carinii and yeast clinical isolates.

F. Barchiesi, G. Scalise, A. Giacometti, 1999, The Journal of antimicrobial chemotherapy.

RNAIII-inhibiting peptide improves efficacy of clinically used antibiotics in a murine model of staphylococcal sepsis

V. Saba, R. Ghiselli, G. Scalise, 2005, Peptides.

Structural features of distinctin affecting peptide biological and biochemical properties.

A. Scaloni, C. Potrich, R. Vitale, 2008, Biochemistry.

In-vitro activity of lytic peptides alone and in combination with macrolides and inhibitors of dihydrofolate reductase against Pneumocystis carinii.

F. Barchiesi, G. Scalise, A. Giacometti, 1998, The Journal of antimicrobial chemotherapy.

In vitro effect on Cryptosporidium parvum of short-term exposure to cathelicidin peptides.

M. Zanetti, G. Scalise, A. Giacometti, 2003, The Journal of antimicrobial chemotherapy.

Clinical and mycological evaluation of fluconazole in the secondary prophylaxis of esophageal candidiasis in AIDS patients

F. Chiodo, D. Greco, L. Minoli, 1994, European Journal of Epidemiology.

Effects of the antimicrobial peptide BMAP-27 in a mouse model of obstructive jaundice stimulated by lipopolysaccharide

V. Saba, R. Ghiselli, M. Zanetti, 2006, Peptides.

THE CATHELICIDIN-DERIVED TRITRPTICIN ENHANCES THE EFFICACY OF ERTAPENEM IN EXPERIMENTAL RAT MODELS OF SEPTIC SHOCK

V. Saba, R. Ghiselli, G. Scalise, 2006, Shock.

LL-37 Protects Rats against Lethal Sepsis Caused by Gram-Negative Bacteria

M. Rocchi, V. Saba, R. Ghiselli, 2006, Antimicrobial Agents and Chemotherapy.

The antimicrobial peptide BMAP-28 reduces lethality in mouse models of staphylococcal sepsis*

V. Saba, R. Ghiselli, M. Zanetti, 2004, Critical care medicine.

Neutralization of Endotoxin In Vitro and In Vivo by BAC7(1-35), a Proline-Rich Antibacterial Peptide

V. Saba, R. Ghiselli, M. Zanetti, 2003, Shock.

Comparative analysis of pathogenicity of Cryptococcus neoformans serotypes A, D and AD in murine cryptococcosis.

B. Wickes, M. Cogliati, F. Barchiesi, 2005, The Journal of infection.

Potential therapeutic role of histatin derivative P-113d in experimental rat models of Pseudomonas aeruginosa sepsis.

W. Kamysz, V. Saba, R. Ghiselli, 2004, The Journal of infectious diseases.

Cyclosporiasis in a traveler returning from South America.

G. Scalise, A. Giacometti, O. Cirioni, 1998, Journal of travel medicine.

Tachyplesin III and granulocyte-colony stimulating factor enhance the efficacy of tazobactam/piperacillin in a neutropenic mouse model of polymicrobial peritonitis

M. Rocchi, W. Kamysz, V. Saba, 2008, Peptides.

Amphibian peptides prevent endotoxemia and bacterial translocation in bile duct–ligated rats*

W. Kamysz, V. Saba, R. Ghiselli, 2006, Critical care medicine.

In vitro anti-cryptosporidial activity of cationic peptides alone and in combination with inhibitors of ion transport systems.

F. Barchiesi, G. Scalise, A. Giacometti, 2000, The Journal of antimicrobial chemotherapy.

Activity of nitazoxanide alone and in combination with azithromycin and rifabutin against Cryptosporidium parvum in cell culture.

F. Barchiesi, G. Scalise, A. Giacometti, 2000, The Journal of antimicrobial chemotherapy.

In-vitro activity of atovaquone, sulphamethoxazole and dapsone alone and combined with inhibitors of dihydrofolate reductase and macrolides against Pneumocystis carinii.

G. Scalise, A. Giacometti, O. Cirioni, 1997, The Journal of antimicrobial chemotherapy.

In-vitro activity of macrolides alone and in combination with artemisin, atovaquone, dapsone, minocycline or pyrimethamine against Cryptosporidium parvum.

G. Scalise, A. Giacometti, O. Cirioni, 1996, The Journal of antimicrobial chemotherapy.

Antiseptic Compounds Still Active Against Bacterial Strains Isolated from Surgical Wound Infections Despite Increasing Antibiotic Resistance

V. Saba, R. Ghiselli, G. Scalise, 2002, European Journal of Clinical Microbiology and Infectious Diseases.

In vitro activity of MSI-78 alone and in combination with antibiotics against bacteria responsible for bloodstream infections in neutropenic patients.

W. Kamysz, G. Scalise, A. Giacometti, 2005, International journal of antimicrobial agents.

In vitro and in vivo activity of aurintricarboxylic acid preparations against Cryptosporidium parvum

G. Scalise, P. Klein, A. Giacometti, 2008, The Journal of antimicrobial chemotherapy.

Benefit of oral zinc supplementation as an adjunct to zidovudine (AZT) therapy against opportunistic infections in aids

G. Scalise, E. Mocchegiani, N. Fabris, 1995 .

In Vitro Anticryptosporidial Activity of Ranalexin Alone and in Combination with Other Peptides and with Hydrophobic Antibiotics

F. Barchiesi, G. Scalise, A. Giacometti, 1999, European Journal of Clinical Microbiology and Infectious Diseases.

Efficacy of the bovine antimicrobial peptide indolicidin combined with piperacillin/tazobactam in experimental rat models of polymicrobial peritonitis

V. Saba, R. Ghiselli, G. Scalise, 2008, Critical care medicine.

Effects of pexiganan alone and combined with betalactams in experimental endotoxic shock

J. Łukasiak, W. Kamysz, V. Saba, 2005, Peptides.

Single-Dose Intraperitoneal Magainins Improve Survival in a Gram-Negative-Pathogen Septic Shock Rat Model

M. Rocchi, V. Saba, R. Ghiselli, 2002, Antimicrobial Agents and Chemotherapy.

Therapeutic efficacy of the polymyxin-like peptide ranalexin in an experimental model of endotoxemia.

V. Saba, R. Ghiselli, G. Scalise, 2001, The Journal of surgical research.

Caspofungin in Combination with Amphotericin B against Candida parapsilosis

F. Barchiesi, G. Scalise, E. Spreghini, 2006, Antimicrobial Agents and Chemotherapy.

Effects of Caspofungin against Candida guilliermondii and Candida parapsilosis

F. Barchiesi, G. Scalise, E. Spreghini, 2006, Antimicrobial Agents and Chemotherapy.

In-vitro activity of topoisomerase inhibitors against Pneumocystis carinii.

G. Scalise, A. Giacometti, O. Cirioni, 1997, The Journal of antimicrobial chemotherapy.

Emergence of oropharyngeal candidiasis caused by non-albicans species of Candida in HIV-infected patients

F. Barchiesi, G. Scalise, F. Ancarani, 1993, European Journal of Epidemiology.

In vitro activity of five antifungal agents against clinical isolates of Saccharomyces cerevisiae.

F. Barchiesi, L. Di Francesco, G. Scalise, 1998, Medical mycology.

In Vitro Activity and Killing Effect of Citropin 1.1 against Gram-Positive Pathogens Causing Skin and Soft Tissue Infections

J. Łukasiak, W. Kamysz, G. Scalise, 2005, Antimicrobial Agents and Chemotherapy.

Cathelicidin peptide sheep myeloid antimicrobial peptide-29 prevents endotoxin-induced mortality in rat models of septic shock.

V. Saba, R. Ghiselli, M. Zanetti, 2004, American journal of respiratory and critical care medicine.

Irritable Bowel Syndrome in Patients with Blastocystis hominis Infection

G. Scalise, A. Giacometti, O. Cirioni, 1999, European Journal of Clinical Microbiology and Infectious Diseases.

Antimicrobial Resistance: A Challenge for the Future

P. Barbadoro, E. Prospero, M. D'Errico, 2020 .

Prevalence and antifungal susceptibility of vaginal yeasts in outpatients attending a gynecological center in Ancona, Italy

M. Del Poeta, A. Offidani, G. Scalise, 1997, European Journal of Epidemiology.

Experimental Induction of Fluconazole Resistance in Candida tropicalis ATCC 750

D. Sanglard, F. Barchiesi, G. Scalise, 2000, Antimicrobial Agents and Chemotherapy.

In-vitro interaction of terbinafine with amphotericin B, fluconazole and itraconazole against clinical isolates of Candida albicans.

F. Barchiesi, L. Di Francesco, G. Scalise, 1998, The Journal of antimicrobial chemotherapy.

Dynamics of molecular parameters of human immunodeficiency virus type 1 activity in vivo

M. Clementi, A. Manzin, P. Bagnarelli, 1994, Journal of virology.

Temporin A alone and in combination with imipenem reduces lethality in a mouse model of staphylococcal sepsis.

J. Łukasiak, W. Kamysz, V. Saba, 2005, Journal of Infectious Diseases.

experimental murine candidiasis model. cavities of patients with AIDS in an albicans strains sequentially isolated from oral Variation in fluconazole efficacy for Candida

M. Rinaldi, F. Barchiesi, G. Scalise, 2013 .

Genotypic identification of sequentialCandida albicans isolates from AIDS patients by polymerase chain reaction techniques

F. Barchiesi, G. Scalise, D. Arzeni, 1997, European Journal of Clinical Microbiology and Infectious Diseases.

Genotyping and antifungal susceptibility of human subgingival Candida albicans isolates.

G. Giuliana, F. Barchiesi, G. Scalise, 2002, Archives of oral biology.

In Vitro Activity of the New Echinocandin Antifungal, MK-0991, against Common and Uncommon Clinical Isolates of Candida Species

M. Rinaldi, A. Fothergill, F. Barchiesi, 1999, European Journal of Clinical Microbiology and Infectious Diseases.

Comparison of Three Methods for Testing Azole Susceptibilities of Candida albicans Strains Isolated Sequentially from Oral Cavities of AIDS Patients

M. Cogliati, A. Tortorano, A. Rigoni, 1998, Journal of Clinical Microbiology.

Fluconazole susceptibility and strain variation of Candida albicans isolates from HIV-infected patients with oropharyngeal candidosis.

F. Chiodo, F. Barchiesi, G. Scalise, 1998, The Journal of antimicrobial chemotherapy.

Variation in fluconazole efficacy for Candida albicans strains sequentially isolated from oral cavities of patients with AIDS in an experimental murine candidiasis model

J. Graybill, M. Rinaldi, F. Barchiesi, 1996, Antimicrobial agents and chemotherapy.

Fluconazole and ketoconazole in the treatment of oral and esophageal candidiasis in AIDS patients.

G. Crescenzi, F. Barchiesi, G. Scalise, 1992, Journal of chemotherapy.

PREVALENCE OF INTESTINAL PARASITES AMONG INDIVIDUALS WITH ALLERGIC SKIN DISEASES

L. Antonicelli, G. Scalise, A. Giacometti, 2003, The Journal of parasitology.

PREVALENCE OF INTESTINAL PARASITES AMONG INDIVIDUALS WITH ALLERGIC SKIN

L. Antonicelli, G. Scalise, A. Giacometti, 2003 .

Posaconazole against Candida glabrata Isolates with Various Susceptibilities to Fluconazole

F. Barchiesi, G. Scalise, E. Spreghini, 2008, Antimicrobial Agents and Chemotherapy.

Therapeutic efficacy of buforin II and rifampin in a rat model of Acinetobacter baumannii sepsis

V. Saba, R. Ghiselli, G. Scalise, 2009, Critical care medicine.

Efficacy of the amphibian peptide distinctin in a neutropenic mouse model of staphylococcal sepsis

A. Scaloni, A. Salzano, V. Saba, 2008, Critical care medicine.

In Vitro Activities of the Lipopeptides Palmitoyl (Pal)-Lys-Lys-NH2 and Pal-Lys-Lys Alone and in Combination with Antimicrobial Agents against Multiresistant Gram-Positive Cocci

M. Okrój, W. Kamysz, G. Scalise, 2006, Antimicrobial Agents and Chemotherapy.

Therapeutic efficacy of the magainin analogue MSI-78 in different intra-abdominal sepsis rat models.

W. Kamysz, V. Saba, R. Ghiselli, 2004, The Journal of antimicrobial chemotherapy.

In vitro activities of terbinafine in combination with fluconazole and itraconazole against isolates of Candida albicans with reduced susceptibility to azoles

F. Barchiesi, G. Scalise, L. Falconi Di Francesco, 1997, Antimicrobial agents and chemotherapy.

Transmission of fluconazole-resistant Candida albicans between patients with AIDS and oropharyngeal candidiasis documented by pulsed-field gel electrophoresis.

M. Del Poeta, M. Pfaller, M. Rinaldi, 1995, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

DNA subtypes and fluconazole susceptibilities of Candida albicans isolates from the oral cavities of patients with AIDS.

M. Pfaller, M. Rinaldi, F. Barchiesi, 1995, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

In-Vitro Activity of the Synthetic Protegrin IB-367 Alone and in Combination with Antifungal Agents Against Clinical Isolates of Candida spp.

J. Łukasiak, W. Kamysz, F. Barchiesi, 2007, Journal of chemotherapy.

In vitro activity of Tachyplesin III alone and in combination with terbinafine against clinical isolates of dermatophytes

I. Lenci, W. Kamysz, A. Offidani, 2009, Peptides.

Clinical Manifestations and Molecular Epidemiology of Late Recurrent Candidemia, and Implications for Management

D. Snydman, V. Yu, A. Morris, 2000, European Journal of Clinical Microbiology and Infectious Diseases.

Administration of protegrin peptide IB-367 to prevent endotoxin induced mortality in bile duct ligated rats

W. Kamysz, V. Saba, R. Ghiselli, 2003, Gut.

Efficacy of Caspofungin against Aspergillus terreus

A. Santinelli, M. Rinaldi, A. Fothergill, 2005, Antimicrobial Agents and Chemotherapy.

Strongyloides stercoralis infection: unknown transmission or late recrudescence?

G. Scalise, A. Giacometti, O. Cirioni, 1998, The Journal of infection.

In Vitro Activities of the New Antifungal Triazole SCH 56592 against Common and Emerging Yeast Pathogens

L. Di Francesco, M. Rinaldi, A. Fothergill, 2000, Antimicrobial Agents and Chemotherapy.

A waterborne outbreak of leptospirosis.

F. Di Stanislao, G. Scalise, L. Ciceroni, 1987, American journal of epidemiology.

Comparison of four methods for DNA typing of clinical isolates of Candida glabrata.

F. Barchiesi, L. Di Francesco, G. Scalise, 1999, Journal of medical microbiology.

The lipopeptides Pal–Lys–Lys–NH2 and Pal–Lys–Lys soaking alone and in combination with intraperitoneal vancomycin prevent vascular graft biofilm in a subcutaneous rat pouch model of staphylococcal infection

W. Kamysz, V. Saba, R. Ghiselli, 2007, Peptides.

Temporin A Soaking in Combination with Intraperitoneal Linezolid Prevents Vascular Graft Infection in a Subcutaneous Rat Pouch Model of Infection with Staphylococcus epidermidis with Intermediate Resistance to Glycopeptides

M. Rocchi, J. Łukasiak, W. Kamysz, 2004, Antimicrobial Agents and Chemotherapy.

In-vitro activity of dicationic aromatic compounds and fluconazole against Cryptococcus neoformans and Candida spp.

M. Del Poeta, J. Perfect, D. Boykin, 1999, The Journal of antimicrobial chemotherapy.

Survival of Zidovudine-Treated Patients With AIDS Compared With That of Contemporary Untreated Patients

Carlo Tomino, Donato Greco, Marco Floridia, 1992 .

Contribution of zinc to reduce CD4+ risk factor for 'severe' infection relapse in aging: parallelism with HIV.

G. Scalise, C. Viticchi, E. Mocchegiani, 1999, International journal of immunopharmacology.

In Vitro Activity of Posaconazole against Clinical Isolates of Dermatophytes

A. Offidani, F. Barchiesi, G. Scalise, 2001, Journal of Clinical Microbiology.

Standardization of antifungal susceptibility testing and clinical relevance.

J. Martínez-Suárez, A. Espinel-Ingroff, F. Barchiesi, 1998, Medical mycology.

Tinea capitis due to Microsporum gypseurn in an adult Durch MicrosPorum Dpseum verursachte Tinea capitis bei einem Erwachsenen

A. Offidani, G. Scalise, D. Arzeni, 2007 .

Interactions of Posaconazole and Flucytosine against Cryptococcus neoformans

J. Graybill, L. Di Francesco, F. Barchiesi, 2001, Antimicrobial Agents and Chemotherapy.

Interactions between Triazoles and Amphotericin B against Cryptococcus neoformans

L. Di Francesco, F. Barchiesi, G. Scalise, 2000, Antimicrobial Agents and Chemotherapy.

In-vitro interactions of itraconazole with flucytosine against clinical isolates of Cryptococcus neoformans.

F. Barchiesi, L. Di Francesco, G. Scalise, 1999, The Journal of antimicrobial chemotherapy.

Comparison of broth dilution and semisolid agar dilution for in vitro susceptibility testing of Cryptococcus neoformans.

M. Del Poeta, F. Barchiesi, G. Scalise, 1994, Journal of chemotherapy.

In vitro activity of the lipopeptide derivative (Pal‐lys‐lys‐NH2), alone and in combination with antifungal agents, against clinical isolates of dermatophytes

W. Kamysz, A. Offidani, G. Ganzetti, 2009, The British journal of dermatology.

Tinea capitis due to Microsporum gypseum in an adult

A. Offidani, G. Scalise, D. Arzeni, 1998, Mycoses.

Turbidimetric and visual criteria for in vitro susceptibility testing of Cryptococcus neoformans clinical isolates

F. Barchiesi, G. Scalise, D. Arzeni, 1994, Mycoses.

Turbidimetric and visual criteria for determining the in vitro activity of six antifungal agents againstCandida spp. andCryptococcus neoformans

F. Barchiesi, G. Scalise, M. Poeta, 1993, Mycopathologia.

In Vitro Activity of the New Echinocandin Antifungal, MK-0991, against Common and Uncommon Clinical Isolates of

M. Rinaldi, A. Fothergill, F. Barchiesi, 1999 .

In vitro activity of terbinafine against clinical isolates of dermatophytes.

A. Offidani, F. Barchiesi, G. Scalise, 1998, Medical mycology.

Fluconazole Susceptibility of Candida spp. Isolates Collected Over Nine Years in a Teaching Hospital of Ancona, Italy

F. Barchiesi, G. Scalise, E. Spreghini, 2007, Journal of chemotherapy.

Electrophoretic Karyotyping and Triazole Susceptibility of Candida glabrata Clinical Isolates

F. Barchiesi, G. Scalise, D. Arzeni, 1999, European Journal of Clinical Microbiology and Infectious Diseases.

Epidemiologic features of intestinal parasitic infections in Italian mental institutions

G. Scalise, A. Giacometti, O. Cirioni, 1997, European Journal of Epidemiology.

Temporin A is effective in MRSA-infected wounds through bactericidal activity and acceleration of wound repair in a murine model

W. Kamysz, V. Saba, A. Offidani, 2008, Peptides.

Analysis of antibody response to Cryptococcus neoformans in five patients with AIDS and cryptococcosis by immunoblotting.

F. Barchiesi, G. Scalise, J. Burnie, 2000, The Journal of infection.

Infection due to Absidia corymbifera in a patient with a massive crush trauma of the foot.

F. Barchiesi, G. Scalise, M. Viviani, 1999, The Journal of infection.

Efficacy of colistin/rifampin combination in experimental rat models of sepsis due to a multiresistant Pseudomonas aeruginosa strain*

M. Rocchi, V. Saba, R. Ghiselli, 2007, Critical care medicine.

Effect of pentamidine on the growth of Cryptococcus neoformans.

M. Del Poeta, F. Barchiesi, G. Scalise, 1994, The Journal of antimicrobial chemotherapy.

Antifungal susceptibility patterns of yeast isolates causing bloodstream infections.

M. Montagna, G. Caggiano, F. Barchiesi, 2003, The Journal of antimicrobial chemotherapy.

In vitro activity of synthetic antimicrobial peptides against Candida.

M. Okrój, W. Kamysz, F. Barchiesi, 2006, Polish journal of microbiology.

Electrophoretic karyotyping and antifungal susceptibility patterns of Candida parapsilosis clinical isolates causing deep and superficial fungal infections

A. Offidani, F. Barchiesi, L. Di Francesco, 2004, Mycopathologia.

Fluconazole, itraconazole and ketoconazole in-vitro activity. A comparative study.

F. Barchiesi, G. Scalise, D. Arzeni, 1991, Journal of chemotherapy.

Point prevalence, microbiology and fluconazole susceptibility patterns of yeast isolates colonizing the oral cavities of HIV-infected patients in the era of highly active antiretroviral therapy.

F. Barchiesi, G. Scalise, D. Arzeni, 2002, The Journal of antimicrobial chemotherapy.

In vitro activity of the synthetic lipopeptide PAL-Lys-Lys-NH2 alone and in combination with antifungal agents against clinical isolates of Cryptococcus neoformans

Wojciech Kamysz, Andrea Giacometti, Francesco Barchiesi, 2007, Peptides.

In vitro and in vivo anticryptococcal activities of a new pyrazolo-isothiazole derivative.

G. Pizzo, F. Barchiesi, G. Scalise, 2003, The Journal of antimicrobial chemotherapy.

Posaconazole Prophylaxis in Experimental Systemic Zygomycosis

A. Santinelli, M. Rinaldi, A. Fothergill, 2006, Antimicrobial Agents and Chemotherapy.

Posaconazole Prophylaxis in Experimental Systemic Zygomycosis (cid:1)

A. Santinelli, M. Rinaldi, A. Fothergill, 2006 .

Tolerance to amphotericin B in clinical isolates of Candida tropicalis.

F. Barchiesi, G. Scalise, E. Spreghini, 2004, Diagnostic microbiology and infectious disease.

Unusual clinical presentation of infection due to Flavimonas oryzihabitans.

G. Scalise, A. Giacometti, O. Cirioni, 1998, European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology.

Environmental and serological evidence for the presence of toxocariasis in the urban area of Ancona, Italy

M. D'Errico, L. Antonicelli, G. Scalise, 2004, European Journal of Epidemiology.

Unusual clinical presentation of infection due toFlavimonas oryzihabitans

G. Scalise, A. Giacometti, O. Cirioni, 1998, European Journal of Clinical Microbiology and Infectious Diseases.

In-vitro activity of rifabutin and albendazole singly and in combination with other clinically used antimicrobial agents against Pneumocystis carinii.

F. Barchiesi, G. Scalise, A. Giacometti, 1999, The Journal of antimicrobial chemotherapy.

Nonmycetomic Actinomadura madurae infection in a patient with AIDS

M. McNeil, G. Scalise, J. Brown, 1992, Journal of clinical microbiology.

Efficacy of Treatment with Paromomycin, Azithromycin, and Nitazoxanide in a Patient with Disseminated Cryptosporidiosis

F. Barchiesi, G. Scalise, A. Giacometti, 1999, European Journal of Clinical Microbiology and Infectious Diseases.

Prevalence and clinical relevance of Blastocystis hominis in diverse patient cohorts

G. Scalise, A. Giacometti, O. Cirioni, 1999, European Journal of Epidemiology.

Comparative Efficacies of Quinupristin-Dalfopristin, Linezolid, Vancomycin, and Ciprofloxacin in Treatment, Using the Antibiotic-Lock Technique, of Experimental Catheter-Related Infection Due to Staphylococcus aureus

M. Provinciali, V. Saba, R. Ghiselli, 2005, Antimicrobial Agents and Chemotherapy.

In Vitro Activity of Aurein 1.2 Alone and in Combination with Antibiotics against Gram-Positive Nosocomial Cocci

Wojciech Kamysz, Andrea Giacometti, J. Łukasiak, 2007, Antimicrobial Agents and Chemotherapy.

Efficacy of polycationic peptides in preventing vascular graft infection due to Staphylococcus epidermidis.

L. Goffi, V. Saba, R. Ghiselli, 2000, The Journal of antimicrobial chemotherapy.

Anticryptosporidial activity of ranalexin, lasalocid and azithromycin alone and in combination in cell lines.

F. Barchiesi, G. Scalise, A. Giacometti, 2000, The Journal of antimicrobial chemotherapy.

Importance of Baseline Prognostic Factors With Increasing Time Since Initiation of Highly Active Antiretroviral Therapy: Collaborative Analysis of Cohorts of HIV-1-Infected Patients

Anne M Johnson, A. Trkola, J. Sterne, 2007, Journal of acquired immune deficiency syndromes.

BMAP-28 improves the efficacy of vancomycin in rat models of gram-positive cocci ureteral stent infection

V. Saba, R. Ghiselli, M. Zanetti, 2008, Peptides.

RNAIII-INHIBITING PEPTIDE IN COMBINATION WITH THE CATHELICIDIN BMAP-28 REDUCES LETHALITY IN MOUSE MODELS OF STAPHYLOCOCCAL SEPSIS

V. Saba, R. Ghiselli, M. Zanetti, 2006, Shock.

Pre-treatment of central venous catheters with the cathelicidin BMAP-28 enhances the efficacy of antistaphylococcal agents in the treatment of experimental catheter-related infection

V. Saba, R. Ghiselli, M. Zanetti, 2006, Peptides.

Primary resistance to flucytosine among clinical isolates of Candida spp.

F. Barchiesi, G. Scalise, D. Arzeni, 2000, The Journal of antimicrobial chemotherapy.

Outbreak of fungemia due to Candida parapsilosis in a pediatric oncology unit.

M. Montagna, G. Caggiano, F. Barchiesi, 2004, Diagnostic microbiology and infectious disease.

RNAIII-Inhibiting Peptide Affects Biofilm Formation in a Rat Model of Staphylococcal Ureteral Stent Infection

V. Saba, R. Ghiselli, G. Scalise, 2007, Antimicrobial Agents and Chemotherapy.

When to start highly active antiretroviral therapy in chronically HIV-infected patients: evidence from the ICONA study

M. Moroni, A. d’Arminio Monforte, A. Phillips, 2001, AIDS.

Report of the symposium on the use of intravenous gammaglobulin in adults infected with the human immunodeficiency virus

R. Lockey, C. De Simone, R. Good, 1990, Journal of clinical laboratory analysis.

Strongyloides stercoralis first-stage larvae in the lungs of a patient with AIDS: primary localization or a noninvasive form of dissemination?

G. Scalise, A. Giacometti, O. Cirioni, 1996, Clinical Infectious Diseases.

[Prevalence of Toxocara spp in public playgrounds in a town of Central Italy]

M. D'Errico, G. Scalise, A. Giacometti, 1999, Le infezioni in medicina : rivista periodica di eziologia, epidemiologia, diagnostica, clinica e terapia delle patologie infettive.

RNAIII-inhibiting peptide and/or nisin inhibit experimental vascular graft infection with methicillin-susceptible and methicillin-resistant Staphylococcus epidermidis.

M. Rocchi, V. Saba, R. Ghiselli, 2004, European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery.

Quinupristin/dalfopristin bonding in combination with intraperitoneal antibiotics prevent infection of knitted polyester graft material in a subcutaneous rat pouch model infected with resistant Staphylococcus epidermidis.

V. Saba, R. Ghiselli, G. Scalise, 2002, European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery.

Efficacy of Quinupristin-Dalfopristin in Preventing Vascular Graft Infection Due to Staphylococcus epidermidis with Intermediate Resistance to Glycopeptides

V. Saba, R. Ghiselli, G. Scalise, 2002, Antimicrobial Agents and Chemotherapy.

Prophylaxis against Staphylococcus aureus vascular graft infection with mupirocin-soaked, collagen-sealed dacron.

L. Goffi, V. Saba, R. Ghiselli, 2001, The Journal of surgical research.

Efficacy of rifampin-levofloxacin as a prophylactic agent in preventing Staphylococcus epidermidis graft infection.

L. Goffi, V. Saba, R. Ghiselli, 2000, European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery.

Mupirocin Prophylaxis against Methicillin-Susceptible, Methicillin-Resistant, or Vancomycin-IntermediateStaphylococcus epidermidis Vascular-Graft Infection

A. Riva, L. Goffi, V. Saba, 2000, Antimicrobial Agents and Chemotherapy.

Experimental study on the efficacy of combination of α-helical antimicrobial peptides and vancomycin against Staphylococcus aureus with intermediate resistance to glycopeptides

V. Saba, R. Ghiselli, G. Scalise, 2006, Peptides.

Use of the quorum-sensing inhibitor RNAIII-inhibiting peptide to prevent biofilm formation in vivo by drug-resistant Staphylococcus epidermidis.

V. Saba, R. Ghiselli, G. Scalise, 2003, The Journal of infectious diseases.

RNA III Inhibiting Peptide Inhibits In Vivo Biofilm Formation by Drug-Resistant Staphylococcus aureus

V. Saba, R. Ghiselli, G. Scalise, 2003, Antimicrobial Agents and Chemotherapy.

Distinctin improves the efficacies of glycopeptides and betalactams against staphylococcal biofilm in an experimental model of central venous catheter infection.

A. Scaloni, G. Renzone, V. Saba, 2007, Journal of biomedical materials research. Part A.

Citropin 1.1-treated central venous catheters improve the efficacy of hydrophobic antibiotics in the treatment of experimental staphylococcal catheter-related infection

J. Łukasiak, W. Kamysz, V. Saba, 2006, Peptides.

Treatment of Staphylococcus aureus Biofilm Infection by the Quorum-Sensing Inhibitor RIP

V. Saba, R. Ghiselli, G. Scalise, 2007, Antimicrobial Agents and Chemotherapy.

A Chimeric Peptide Composed of a Dermaseptin Derivative and an RNA III-Inhibiting Peptide Prevents Graft-Associated Infections by Antibiotic-Resistant Staphylococci

A. Mor, V. Saba, R. Ghiselli, 2004, Antimicrobial Agents and Chemotherapy.

Prophylactic efficacy of linezolid alone or combined with levofloxacin and vancomycin in a rat subcutaneous pouch model of graft infection caused by Staphylococcus epidermidis with intermediate resistance to glycopeptides.

V. Saba, R. Ghiselli, G. Scalise, 2003, The Journal of antimicrobial chemotherapy.

RNAIII-Inhibiting Peptide Enhances Healing of Wounds Infected with Methicillin-Resistant Staphylococcus aureus

V. Saba, A. Offidani, R. Ghiselli, 2008, Antimicrobial Agents and Chemotherapy.

RNAIII-Inhibiting-Peptide-Loaded Polymethylmethacrylate Prevents In Vivo Staphylococcus aureus Biofilm Formation

Robin Patel, V. Saba, R. Ghiselli, 2006, Antimicrobial Agents and Chemotherapy.

Molecular profile of human immunodeficiency virus type 1 infection in symptomless patients and in patients with AIDS

M. Giacca, M. Clementi, A. Manzin, 1992, Journal of virology.

OpuC – an ABC Transporter that is Associated with Staphylococcus Aureus Pathogenesis

G. Scalise, A. Giacometti, O. Cirioni, 2009 .

In Vitro Activity and Killing Effect of Uperin 3.6 against Gram-Positive Cocci Isolated from Immunocompromised Patients

W. Kamysz, G. Scalise, A. Giacometti, 2005, Antimicrobial Agents and Chemotherapy.

Leuconostoc citreum isolated from lung in AIDS patient

G. Scalise, A. Giacometti, R. Ranaldi, 1993, The Lancet.

Discovery of a Quorum-Sensing Inhibitor of Drug-Resistant Staphylococcal Infections by Structure-Based Virtual Screening

M. Shoham, V. Saba, R. Ghiselli, 2008, Molecular Pharmacology.

Antiendotoxin activity of protegrin analog IB-367 alone or in combination with piperacillin in different animal models of septic shock

J. Łukasiak, W. Kamysz, V. Saba, 2003, Peptides.

Benefit of oral zinc supplementation as an adjunct to zidovudine (AZT) therapy against opportunistic infections in AIDS.

G. Scalise, E. Mocchegiani, N. Fabris, 1997, International journal of immunopharmacology.

BisEDT and RIP act in synergy to prevent graft infections by resistant staphylococci

P. Domenico, V. Saba, R. Ghiselli, 2004, Peptides.

A randomized trial (ISS 901) of switching to didanosine versus continued zidovudine after the diagnosis of AIDS.

M. Moroni, F. Dianzani, F. Mazzotta, 1996, Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association.

Unusual neurological presentation of dipylidiasis in a child

G. Scalise, A. Giacometti, O. Cirioni, 2005, European Journal of Pediatrics.

Comparison of long-term prognosis of patients with AIDS treated and not treated with zidovudine

Anne M Johnson, Andrew N. Phillips, Reggio Emilia, 1994 .

In vitro activity of the new quinolone lomefloxacin against Mycobacterium tuberculosis.

G. Scalise, C. Piersimoni, S. Bornigia, 1992, The American review of respiratory disease.

Pretreatment with the protegrin IB-367 affects Gram-positive biofilm and enhances the therapeutic efficacy of linezolid in animal models of central venous catheter infection.

J. Łukasiak, W. Kamysz, V. Saba, 2007, JPEN. Journal of parenteral and enteral nutrition.

Suppression of drug-resistant Staphylococcal Infections by the quorum-sensing inhibitor RNAIII-inhibiting peptide.

V. Saba, R. Ghiselli, G. Scalise, 2004, The Journal of infectious diseases.

In-vitro activity of terbinafine, atovaquone and co-trimoxazole against Pneumocystis carinii.

G. Scalise, A. Giacometti, O. Cirioni, 1995, The Journal of antimicrobial chemotherapy.

OpuC--an ABC transporter that is associated with Staphylococcus aureus pathogenesis.

G. Scalise, A. Giacometti, O. Cirioni, 2009, International Journal of Artificial Organs.

A randomized trial comparing the introduction of ritonavir or indinavir in 1251 nucleoside-experienced patients with advanced HIV infection.

M. Moroni, L. Contu, A. Lazzarin, 2000, AIDS Research and Human Retroviruses.

In vitro activity and killing effect of temporin A on nosocomial isolates of Enterococcus faecalis and interactions with clinically used antibiotics.

W. Kamysz, G. Scalise, A. Giacometti, 2005, The Journal of antimicrobial chemotherapy.

Genotypic variation and antifungal susceptibilities of Candida pelliculosa clinical isolates.

A. Tortorano, A. Rigoni, F. Barchiesi, 2005, Journal of medical microbiology.

Clinical results of a multicenter study with sulbactam/ampicillin for the treatment of patients with lower respiratory and urinary tract infections.

F. Chiodo, C. De Simone, S. Delia, 1991, Journal of chemotherapy.

In vitro effect of short-term exposure to two synthetic peptides, alone or in combination with clarithromycin or rifabutin, on Cryptosporidium parvum infectivity

F. Kasprzykowski, W. Kamysz, F. Barchiesi, 2002, Peptides.

Echinococcus granulosus: diagnosis of human hydatid disease by the indirect haemoagglutination reaction with antigens from hydatid fluid and scoleces.

G. Scalise, C. Tassi, S. Dottorini, 1981, International journal for parasitology.

RNAIII-inhibiting peptide significantly reduces bacterial load and enhances the effect of antibiotics in the treatment of central venous catheter-associated Staphylococcus aureus infections.

V. Saba, R. Ghiselli, G. Scalise, 2006, The Journal of infectious diseases.

Sequential Therapy with Caspofungin and Fluconazole for Candida albicans Infection

F. Barchiesi, G. Scalise, E. Spreghini, 2004, Antimicrobial Agents and Chemotherapy.

Anticryptosporidial activity of paromomycin.

G. Scalise, A. Giacometti, O. Cirioni, 1995, The Journal of infectious diseases.

Tuberculosis: Medico-Legal Aspects

V. Pascali, D. Buonsenso, P. Valentini, 2014, Mediterranean journal of hematology and infectious diseases.

Therapeutic efficacy of intraperitoneal polymyxin B and polymyxin-like peptides alone or combined with levofloxacin in rat models of septic shock.

F. Kasprzykowski, W. Kamysz, V. Saba, 2002, The Journal of antimicrobial chemotherapy.

Mixed mycobacterial infection of cervical lymph nodes.

P. Giorgi, G. Scalise, C. Piersimoni, 1991, The Pediatric infectious disease journal.

Discovery of a Quorum-Sensing Inhibitor of Drug-Resistant Staphylococcal Infections by Structure-Based Virtual Screening

M. Shoham, V. Saba, R. Ghiselli, 2008, Molecular Pharmacology.

Treatment of Staphylococcus aureus Biofilm Infection by the Quorum-Sensing Inhibitor RIP

V. Saba, R. Ghiselli, G. Scalise, 2007, Antimicrobial Agents and Chemotherapy.

RNAIII-inhibiting peptide significantly reduces bacterial load and enhances the effect of antibiotics in the treatment of central venous catheter-associated Staphylococcus aureus infections.

V. Saba, R. Ghiselli, G. Scalise, 2006, The Journal of infectious diseases.

Interactions between Triazoles and Amphotericin B against Cryptococcus neoformans

L. Di Francesco, F. Barchiesi, G. Scalise, 2000, Antimicrobial Agents and Chemotherapy.

Efficacy of Tachyplesin III, Colistin, and Imipenem against a Multiresistant Pseudomonas aeruginosa Strain

J. Łukasiak, W. Kamysz, V. Saba, 2007, Antimicrobial Agents and Chemotherapy.

[Giardiasis: a parasitic disease of continued topicality. Study of prevalence among a selected adult population]

M. D'Errico, G. Scalise, A. Giacometti, 2000, Le infezioni in medicina : rivista periodica di eziologia, epidemiologia, diagnostica, clinica e terapia delle patologie infettive.